FBN1 silencing leads to decreased papillary thyroid carcinoma cell proliferation and enhances apoptosis in vitro, up-regulation of FBN1 boosts xenograft tumor formation in vivo (Ma et al., 2016). Here, FBN1 is linked to differentiated thyroid carcinoma.